|
Multimedia
Images, audio, and video related to cancer research
Calendar
Meetings, seminars, and press conferences focused on cancer research
Resources
Information on cancer types, treatment, prevention, and more
 Sponsored by:
The Cancer News Portal is supported by the National Cancer Institute of the National Institutes of Health. Additional information on cancer research, prevention, and treatment is available at www.cancer.gov |
Breaking News
Key: Meeting
Showing releases 1001-1025 out of 1124. << < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 > >>
Public Release: 22-Jun-2012
 Brain Disorders & TherapyGMCSF treatment associated with improved cognition in cancer patients Growth factors shown to cure Alzheimer's disease in a mouse model and administered to cancer patients as part of their treatment regimen were linked to significant improvements in the patients' cognitive function following stem cell transplantation, a preliminary clinical study reports. 
American Cancer Society, Byrd Alzheimer's Institute
Contact: Anne DeLotto Baier
Public Release: 22-Jun-2012
Grb2 holds powerful molecular signaling pathway in check Once considered merely a passive link between proteins that matter, Grb2 - pronounced "grab2" - actually lives up to its nickname with its controlling grip on an important cell signaling pathway, scientists at the University of Texas MD Anderson Cancer Center report in the June 22 issue of Cell. Contact: Scott Merville
Public Release: 21-Jun-2012
BrainMultiple sclerosis patients have lower risk of cancer: UBC-VCH research Multiple sclerosis patients appear to have a lower cancer risk, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health.
Canadian Institutes of Health Research, Multiple Sclerosis Society of Canada, Michael Smith Foundation for Health Research
Contact: Melissa Ashman
Public Release: 21-Jun-2012
Molecular CellEnzyme offers new therapeutic target for cancer drugs Researchers at the University of California, San Diego School of Medicine have uncovered a new signal transduction pathway specifically devoted to the regulation of alternative RNA splicing, a process that allows a single gene to produce or code multiple types of protein variants. The discovery, published in the June 27, 2012 issue of Molecular Cell, suggests the new pathway might be a fruitful target for new cancer drugs.
National Institutes of Health, Ruth L. Kirchstein National Research Service Award, Howard Hughes Medical Institute
Contact: Scott LaFee
Public Release: 21-Jun-2012
Chemistry and BiologyNew candidate drug stops cancer cells, regenerates nerve cells Scientists have developed a small-molecule-inhibiting drug that in early laboratory cell tests stopped breast cancer cells from spreading and also promoted the growth of early nerve cells called neurites. Researchers from Cincinnati Children's Hospital Medical Center report their findings online June 21 in Chemistry & Biology. The scientists named their lead drug candidate "Rhosin" and hope future testing shows it to be promising for the treatment of various cancers or nervous system damage.
National Institutes of Health
Contact: Nick Miller
Public Release: 21-Jun-2012
Nature Reviews CancerMoffitt researchers: Darwin's principles say cancer will always evolve to resist treatment According to researchers at Moffitt Cancer Center, cancer is subject to the evolutionary processes laid out by Charles Darwin in his concept of natural selection. Natural selection was the process identified by Darwin by which nature selects certain physical attributes, or phenotypes, to pass on to offspring to better "fit" the organism to the environment.
NIH/National Cancer Institute
Contact: Patty Kim
Public Release: 21-Jun-2012
Chemistry & BiologyNew anti-inflammatory drugs pinch off reactive oxygen species at the source Scientists have identified a new type of anti-inflammatory compound that may be useful in treating a wide range of conditions, including neurodegenerative and autoimmune diseases. These compounds inhibit the enzyme Nox2, part of a family of enzymes responsible for producing reactive oxygen species.
NIH/National Cancer Institute, National Institutes of Health, NIH/National Institute of Mental Health
Contact: Quinn Eastman
Public Release: 21-Jun-2012
Genes & DevelopmentNotre Dame researcher's paper examines the biology of tumor-derived microvesicles A new paper by Crislyn D'Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients. Contact: Crislyn-D'Souza-Schorey
Public Release: 21-Jun-2012
Journal of Thoracic and Cardiovascular SurgeryTask force recommends new lung cancer screening guidelines A lung screening and surveillance task force, established by the American Association for Thoracic Surgery and led by medical professionals from Brigham and Women's Hospital, is strongly recommending new guidelines for lung cancer screening. The guidelines were published this week in the online edition of the Journal of Thoracic and Cardiovascular Surgery.
American Association for Thoracic Surgery
Contact: Tom Langford
Public Release: 21-Jun-2012
Proceedings of the National Academy of SciencesCancers with disorganized 'traffic systems' more difficult to treat: U of A research Medical researchers at the University of Alberta reviewed test results from thousands of patients with various types of cancer and discovered that "disorganized" cancers were more difficult to treat and consistently resulted in lower survival rates.
Alberta Cancer Foundation
Contact: Raquel Maurier
Public Release: 21-Jun-2012
2012 International Conference on Zebrafish Development and GeneticsVersatility of zebrafish research highlighted at international conference Amazingly, the small, black-and-white striped zebrafish has biological similarities to humans, and is increasingly a popular model organism for studying vertebrate development, genetics, physiology, and mechanisms of disease as featured at the ongoing 2012 International Zebrafish Development and Genetics Conference in Madison, Wisc. Contact: Phyllis Edelman
Public Release: 21-Jun-2012
BloodStopping and starting cancer cell cycle weakens and defeats multiple myeloma Weill Cornell Medical College researchers have devised an innovative boxer-like strategy, based on the serial use of two anti-cancer drugs, to deliver a one-two punch to first weaken the defenses of multiple myeloma and then deliver the final knock-out punch to win the fight.
NIH/National Cancer Institute, Leukemia and Lymphoma Society, Starr Cancer Consortium
Contact: Lauren Woods
Public Release: 20-Jun-2012
NeuronProposed drug may reverse Huntington's disease symptoms With a single drug treatment, researchers at the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine can silence the mutated gene responsible for Huntington's disease, slowing and partially reversing progression of the fatal neurodegenerative disorder in animal models.
CHDI Foundation
Contact: Scott LaFee
Public Release: 20-Jun-2012
NatureGene sequencing project identifies potential drug targets in common childhood brain tumor Researchers studying the genetic roots of the most common malignant childhood brain tumor have discovered missteps in three of the four subtypes of the cancer that involve genes already targeted for drug development.
National Institutes of Health, Pediatric Cancer Genome Project, Collaborative Ependymoma Research Network, Musicians against Childhood Cancer, Noyes Brain Tumour Foundation, ALSAC
Contact: Summer Freeman
Public Release: 20-Jun-2012
NatureBreast cancer's many drivers Breast cancer is not a single disease, but a collection of diseases with dozens of different mutations that crop up with varying frequency across different breast cancer subtypes. In one of the largest breast cancer sequencing efforts to date, scientists from the Broad Institute, the National Institute of Genomic Medicine in Mexico City, Beth Israel Deaconess Medical Center, and Dana-Farber Cancer Institute have discovered surprising alterations in genes not previously associated with breast cancer.
NIH/National Cancer Institute, National Institutes of Health, Carlos Slim Health Institute
Contact: Nicole Davis
Public Release: 20-Jun-2012
American Association for Cancer Research's Pancreatic Cancer: Progress and ChallengesNovel chemotherapy agent appears to be a promising pancreatic cancer treatment A novel chemotherapeutic agent, the highly selective MEK1/2 inhibitor BAY 86-9766, may be a promising future treatment for pancreatic ductal adenocarcinoma, according to preclinical results presented at the American Association for Cancer Research's Pancreatic Cancer: Progress and Challenges conference, held June 18-21. Contact: Jeremy Moore
Public Release: 20-Jun-2012
Journal of the Royal Society of MedicineControversial vaccine trial should never have been run in India, researchers say Research published today in the Journal of the Royal Society of Medicine raises further questions about a trial of HPV vaccines in India. Contact: Kerry Noble
Public Release: 20-Jun-2012
American Association for Cancer Research's Pancreatic Cancer: Progress and ChallengesHigh-fat/calorie diet accelerates development of pancreatic cancer Study results presented at the American Association for Cancer Research's Pancreatic Cancer: Progress and Challenges conference, held June 18-21, strongly suggest that a diet high in fat and calories can hasten the development of pancreatic cancer in humans. Contact: Jeremy Moore
Public Release: 20-Jun-2012
Gynecologic OncologyMisidentified and contaminated cell lines lead to faulty cancer science A University of Colorado Cancer Center study published this week in the journal Gynecologic Oncology shows that due to a high rate of contamination, misidentification and redundancy in widely available cell lines, researchers may be drawing faulty conclusions.
NIH/National Cancer Institute
Contact: Erika Matich
Public Release: 20-Jun-2012
British Journal of Urology InternationalNew drugs, new ways to target androgens in prostate cancer therapy Prostate cancer cells require androgens including testosterone to grow. A recent review in the British Journal of Urology International describes new classes of drugs that target androgens in novel ways, providing alternatives to the traditional methods that frequently carry high side effects. Contact: Erika Matich
Public Release: 20-Jun-2012
Molecular Nutrition and Food ResearchStudy links carcinogens to cancer stem cells -- but spinach can help Researchers for the first time have traced the actions of a known carcinogen in cooked meat to its complex biological effects on microRNA and cancer stem cells. They also found that spinach can help prevent some of the damage done by this carcinogen.
National Institutes of Health
Contact: Rod Dashwood
Public Release: 20-Jun-2012
Clinical Cancer ResearchUW research shows new prognosis tool for deadly brain cancer A diagnosis of glioblastoma multiforme (GBM) is generally a death sentence, but new research from the University of Wisconsin-Madison lab of Dr. John Kuo shows that at least one subtype is associated with a longer life expectancy. This discovery could help with better patient prognoses and lead to targeted drug treatments for GBM subtypes.
NIH/National Cancer Institute, Wisconsin Partnership Program, Center for Stem Cell and Regenerative Medicine, University of Wisconsin-Madison
Contact: Susan Lampert Smith
Public Release: 20-Jun-2012
Journal of Cell ScienceMayo Clinic: Molecule thought cancer foe actually helps thyroid tumors grow A molecule widely believed to fight many forms of cancer actually helps deadly thyroid tumors grow, and cancer therapies now being tested in humans might boost the activity of this newly revealed bad guy, researchers at Mayo Clinic in Florida say. Contact: Kevin Punsky
Public Release: 20-Jun-2012
Husband-wife team set out to improve breast cancer exams Cancer survivors and researchers Lorraine Olson and Robert Throne are working to change the way cancer is diagnosed. Together, this husband-wife team use TACC's supercomputing resources to create mathematical models to improve early detection efforts. This research could be instrumental in the development of a new robotic device that will mimic manual breast exams. Contact: Faith Singer-Villalobos
Public Release: 20-Jun-2012
Naunyn-Schmiedeberg's Archives of PharmacologyDouble the pain: RUB biologists find the cause of pain in the treatment of fair skin cancer Apply the ointment, light on, light off – that's how easy it is to cure various forms of non-melanoma skin cancer. However, the majority of patients suffer severe pain during the so-termed photodynamic therapy. Why the treatment with ointment and red light can be so painful has now been uncovered by researchers from the RUB. They identified the ion channels involved and signaling molecules secreted by the cancer cells. Contact: Dr. Ben Novak
Showing releases 1001-1025 out of 1124. << < 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 > >>
|
Search News Releases
|
|||||||||||||||||||||||||
 |
||||
|
|
 |
|